The partnership between Jona and Everlywell signals a major shift: advanced gut microbiome testing is moving from specialized settings into scalable, consumer-facing platforms.
By combining deep shotgun metagenomic sequencing with AI-driven analysis, the offering goes beyond basic gut tests—aiming to deliver strain-level insights and personalized intervention pathways.
But the real inflection point is distribution.
Through Everlywell’s reach, microbiome testing is no longer confined to early adopters or research settings—it’s being embedded into the mainstream at-home diagnostics ecosystem, accessible to millions.